Impacts of Tardive Dyskinesia (TD) Symptoms on Patients: Analysis of a TD-Specific Patient-Reported Outcome
Objective: To understand the impact of tardive dyskinesia (TD) symptoms on patients, confirm the appropriateness of the Tardive Dyskinesia Impact Scale (TDIS) as a patient-reported…Efficacy and safety of Botulinum toxin (BoNT) in lingual dystonia
Objective: To evaluate the current evidence on the efficacy and safety of BoNT in treating lingual dystonia. Background: Lingual dystonia is a rare yet debilitating…Classifying pain in dystonia: a way to improve pain outcome measure in dystonia.
Objective: To improve the classification system for pain in dystonia. Background: Pain is a frequent and incapacitating non-motor symptom in dystonia. Evidence indicates that pain…Characterizing the temporal discrimination threshold in musician’s dystonia
Objective: To compare the temporal discrimination threshold (TDT) between musician's dystonia (MD) patients, healthy musicians and non-musician controls. Background: MD is a focal, task specific…The online MDS educational resources helped young neurologists maintain their training during the Covid-19 pandemic
Objective: To analyse the impact of the COVID-19 pandemic on the young MDS members assessing their satisfaction with the MDS virtual educational tools. Background: The…Optimizing an Electronic Health Records (EHR)-based Algorithm for Parkinson’s Disease Case Ascertainment
Objective: To develop an EHR-based algorithm to classify patients with PD into three levels of diagnostic certainty. Background: EHRs can be a rich source of…Emerging parkinsonism in the PREDICT-PD cohort after 6-years of follow-up
Objective: To determine how motor features emerge over time in individuals estimated to be at higher risk of Parkinson’s disease (PD), compared with lower risk…Acute functional movement disorder in a Lupus patient
Objective: Movement disorders (MD) in autoimmune diseases are uncommon. However, the initial presentation required that the clinicians characterize the clinical phenomenology. Rheumatological patients' complexity required…Widespread loss of presynaptic terminal marker SV2A in early Huntington’s disease.
Objective: To assess synaptic damage in early stages of Huntington’s disease (HD) in vivo. Background: Synaptic damage has long been suspected to play a major…Risk and timing of manifest Huntington’s disease in patients with reduced penetrance alleles
Objective: To estimate risk of Huntington’s disease (HD) over time in patients with reduced penetrance (RP) alleles (36-39 CAG repeats) overall, by individual repeat length,…
- « Previous Page
- 1
- …
- 39
- 40
- 41
- 42
- 43
- …
- 132
- Next Page »